| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.19 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |